That's interesting because I would have thought that since they were testing OPT302 with Lucentis that there might be some kind of mutual understanding with Novartis already. Apparently not.
That's interesting because I would have thought that since they...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.5¢ |
Change
-0.005(0.60%) |
Mkt cap ! $1.027B | |||
| Open | High | Low | Value | Volume |
| 85.5¢ | 85.5¢ | 82.0¢ | $11.20M | 13.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13018 | 83.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.0¢ | 3897 | 1 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |